Trials / Completed
CompletedNCT05206058
To Exam the Effects of Phyllanthus Niruri Extracts on Human Neutrophils
To Exam the Effects of Phyllanthus Niruri Extracts (Corilagin, Phyllanthin and Brevifolin) on Human Neutrophils
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
To exam the effects of Phyllanthus niruri extracts(corilagin, phyllanthin and brevifolin) on human neutrophils
Detailed description
Phyllanthus niruri extracts have anti-inflammatory effects in various cellular systems (monocytes, neutrophil). However, the underlying effects and mechanisms of Phyllanthus niruri extracts on neutrophils have not yet been investigated in detail. In this study, first we would like to systemic exam the effects of corilagin, phyllanthin and brevifolin, three major active components, on human neutrophils. Further to clarify whether Phyllanthus niruri extracts have any effect on neutrophils that may provide some insights on the ability of these compounds to modulate the innate immune response in acute organ injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | venipuncture | Plan to enroll 240 health people who are 20-35 years of age. People with received veinpuncture. Blood will be collected at time and drawn into Heparin-coated tube. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-09-30
- Completion
- 2023-07-31
- First posted
- 2022-01-25
- Last updated
- 2023-09-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05206058. Inclusion in this directory is not an endorsement.